![privateeyes inc privateeyes inc](https://cdn-5fd0cb44c1ac1a221c18b85c.closte.com/wp-content/uploads/2021/03/AdobeStock_207871235-980x699.jpeg)
Proposal 6: The shareholders, on an advisory basis, ratified the appointment of BPM, LLP. Proposal 5: the shareholders approved the Second Sight 2022 Omnibus Plan, as follows: Proposal 4: The shareholders elected each of the six director nominees to the Board of Directors of the Company to serve until the 2023 Annual Meeting of Shareholders or until their successors have been duly elected and qualified, as follows: Proposal 3: the shareholders approved an amendment to the Second Sight Restated Articles of Incorporation, as amended, to effect the change of name of Second Sight to “Vivani Medical, Inc.”, as follows:
![privateeyes inc privateeyes inc](https://prieyes.com/wp-content/uploads/2019/12/Global-Security-Exchange-Greenville-768x576.jpg)
Proposal 2: the shareholders approved an amendment to the Second Sight Restated Articles of Incorporation, as amended, to effect a reverse stock split of Second Sight’s common stock, within a range, as determined by Second Sight’s board of directors, of one new share for every 2 to 10 (or any number in between) shares outstanding, as follows: Proposal 1: the shareholders approved the Merger Agreement and thereby approved the transactions contemplated thereby, including the merger, the issuance of the merger shares, and the change of control resulting from the merger, as follows: The Board of Directors of the Company unanimously approved each of the Proposals and recommended that the shareholders approve each of the Proposals up for vote at the meeting. (“NPM”) and the transactions contemplated thereby, including the merger, the issuance of new shares, and change of control resulting from the merger, (2) approving a reverse stock split in a range, as determined by the Company’s Board of Directors, of 1:2 to 1:10, (3) changing the Company’s name to Vivani Medical, Inc., (4) electing six members of the Board of Directors, (5) approving the 2022 Omnibus Plan, (6) ratifying the appointment of BPM, LLP as Second Sight’s independent registered public accounting firm for 2022, (7) considering and voting upon an adjournment of the Second Sight annual meeting, if necessary, to solicit additional proxies if there are not sufficient votes in favor of the foregoing proposals. The formal results of the vote are included in a Current Report on Form 8-K filed by the Company with the Securities and Exchange Commission.Īt the annual meeting, the shareholders voted on seven proposals: (1) approving the merger agreement with Nano Precision Medical, Inc.
![privateeyes inc privateeyes inc](https://www.frettedamericana.com/sites/default/files/01549_front_detail_0.jpg)
(NASDAQ: EYES) today announced results of its annual meeting held on July 27, 2022, where the quorum was present.
#Privateeyes inc trial#
Claim your 1-week free trial to StreetInsider Premium here. News and research before you hear about it on CNBC and others.